INTANGIBLE ASSETS (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets
Accumulated Amortization	$ (318,163)	$ (272,141)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	3,806,564	3,371,888
Net Amount	3,488,401	3,099,747
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,769,681	1,721,305
Net Amount	1,769,681	1,721,305
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	250,627	233,275
Net Amount	250,627	233,275
Domestic Utilty Patent - Opera Software [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(9,486)	(8,487)
Net Amount	$ 22,465	$ 23,464
Weighted average remaining amortization period	11 years 3 months	11 years 9 months
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 1,662,562	$ 1,293,614
Accumulated Amortization	(216,934)	(171,911)
Net Amount	$ 1,445,628	$ 1,121,703
Weighted average remaining amortization period	14 years 6 months	15 years
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	$ (91,743)	$ (91,743)